Kristen Kluska's Stock Ratings

Cantor Fitzgerald Analyst

Kristen Kluska is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 01/22/2025

Overall Average Return

26.0%

Smart Score

71.7%

Overall Average Return Percentile

84th

Number of Ratings

225
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

What 14 Analyst Ratings Have To Say About Sarepta Therapeutics
A Glimpse Into The Expert Outlook On Amicus Therapeutics Through 6 Analysts
Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts
Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
Expert Outlook: Ultragenyx Pharmaceutical Through The Eyes Of 11 Analysts
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 15 Analysts
Analyst Expectations For Sarepta Therapeutics's Future
Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings)
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved